| abstract |
The invention relates to compounds of general formula (I) where R and R are as defined in the description of the invention, which are novel anti-inflammatory and antiallergic compounds of the glucocorticosteroid series, as well as methods for producing such compounds, their pharmaceutical compositions, combinations and their therapeutic uses. More specifically, the invention relates to glucocorticosteroids, which are isoxazolidine derivatives. |